ArticleHealth care analysis : HCA : journal of health philosophy and policy2026
Commentary: Quantifying the Human Mortality Costs of Patent-Based Intellectual Property: How Many Premature Deaths are Due to Patents?
Article in Health care analysis : HCA : journal of health philosophy and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This comment reviews he article, "Quantifying the HumanMortality Costs of Patent-based Intellectual Property: How Many PrematureDeaths are due to Patents?", by Joshua M. Pearce and argues that the analysisis overly simplistic.While theaffordability of medicine is a troubling challenge, one must examine thebenefits of intellectual property protection as well as the costs in order toprovide meaningful analysis.By failingto do so the author does us all a disservice by blaming the IP system, anobvious target.The truth is far morenuanced and serious readers deserve an analysis that reflects this and shedslight on the subtleties of the problem rather than turning to an easyscapegoat.Keywords: intellectual property, patents, insulin.
Identifiers
42496804What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.